… Study Evaluating the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a novel high-affinity, long-acting anti-IgE antibody (LP-003) in healthy volunteers
用户qnD1A9QABeHo
1个月前
70
10
已完结
1. 系统已在2025-04-29 15:36:21对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
Y Zhi, N Sun, CR Zhou, H Yang, R Guo, H Ma…
Journal of the American …, 2024
jaad.org
… LP-003 appears to show good safety profile. No Grade 3 and above TEAE was reported. … phase I study of LP-003 suggests that this novel high affinity and long-acting anti-IgE antibody …
